Sonova Holding (OTCMKTS:SONVY) Receives Average Rating of “Hold” from Analysts

Sonova Holding (OTCMKTS:SONVY) has been assigned an average rating of “Hold” from the nine analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, one has given a buy recommendation and two have assigned a strong buy recommendation to the company.

Several research firms recently weighed in on SONVY. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Citigroup reiterated a “sell” rating on shares of Sonova in a research report on Wednesday. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Finally, Jefferies Financial Group cut shares of Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th.

Sonova Stock Performance

OTCMKTS:SONVY opened at $45.39 on Friday. Sonova has a 1 year low of $42.26 and a 1 year high of $68.76. The firm has a 50 day moving average of $45.98 and a 200-day moving average of $50.10. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.